Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Learn About Cancer Care in Your Community

PR Newswire December 30, 2014

Horizon Technology Finance Provides $5 Million Venture Loan to Interleukin Genetics

eTeligis December 30, 2014

Aquinox Pharmaceuticals Initiates Patient Dosing in the Phase 2 Clinical Trial of AQX-1125 in Atopic Dermatitis

GlobeNewswire December 30, 2014

VAPE Holdings Announces Fourth Quarter and Fiscal Year End September 2014 Results

Accesswire December 30, 2014

Genomes of healthy newborns to be sequenced as part of new study

UPI December 30, 2014

Russia to build world's largest DNA databank

UPI December 30, 2014

Rhesus monkeys in Puerto Rico remain vital to research

UPI December 30, 2014

Mother, Grandmother to be Honored for Tissue Donation on Rose Bowl Parade Float

Business Wire December 30, 2014

Tikcro Signs Research and License Agreement Regarding Cancer Immune Checkpoint Antibodies

PR Newswire December 30, 2014

Research and Markets: T-Cell Lymphomas - Pipeline Review, H1 2014

Business Wire December 30, 2014

Aeolus Pharmaceuticals to Present at OneMed Forum SF 2015 Conference

Marketwired December 30, 2014

Idera Provides Key Updates on Clinical Development of IMO-8400 for Treatment of Waldenstrom's Macroglobulinemia

GlobeNewswire December 30, 2014

Green Hills Software to Showcase Its Innovative Solutions for Securing the Connected Car and Designing Safety-Critical Systems

Marketwired December 30, 2014

Synthetic Biologics Announces First Patient Dosed in Phase 1b Clinical Trial of SYN-004 for the Prevention of C. difficile Infection

PR Newswire December 30, 2014

ARIAD Announces Commercialization Agreement for Iclusig in Seven Central and Eastern European Countries

Business Wire December 30, 2014

Advaxis's Cancer Immunotherapies Featured on FOX News' Sunday Housecall

GlobeNewswire December 30, 2014

Cancer Genomics Innovator Personal Genome Diagnostics Adds Business And Management Expertise To Support Rapid Growth

PR Newswire December 30, 2014

OncoGenex to Regain Rights to Custirsen from Teva

Canada NewsWire December 30, 2014

Alexion Completes Rolling BLA Submission to U.S. FDA for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia

Business Wire December 30, 2014

3-V Biosciences Announces Closing of $28.5M Financing Round

Marketwired December 30, 2014